These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26773504)

  • 1. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
    Li Z; Jiang X; Zhang W
    Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
    Pak MG; Shin DH; Lee CH; Lee MK
    World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High KIF2A expression promotes proliferation, migration and predicts poor prognosis in lung adenocarcinoma.
    Xie T; Li X; Ye F; Lu C; Huang H; Wang F; Cao X; Zhong C
    Biochem Biophys Res Commun; 2018 Feb; 497(1):65-72. PubMed ID: 29427669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tumor TROP2 expression with prognosis varies among lung cancer subtypes.
    Inamura K; Yokouchi Y; Kobayashi M; Ninomiya H; Sakakibara R; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
    Oncotarget; 2017 Apr; 8(17):28725-28735. PubMed ID: 28404926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
    Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G
    Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway.
    Liu T; Liu Y; Bao X; Tian J; Liu Y; Yang X
    PLoS One; 2013; 8(9):e75864. PubMed ID: 24086649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
    Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
    Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of TROP2 in human nasopharyngeal carcinoma.
    Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y
    Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of TROP2 expression in patients with gallbladder cancer.
    Chen MB; Wu HF; Zhan Y; Fu XL; Wang AK; Wang LS; Lei HM
    Tumour Biol; 2014 Nov; 35(11):11565-9. PubMed ID: 25135430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
    Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
    Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.
    Fong D; Spizzo G; Gostner JM; Gastl G; Moser P; Krammel C; Gerhard S; Rasse M; Laimer K
    Mod Pathol; 2008 Feb; 21(2):186-91. PubMed ID: 18084248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impact of TROP2 in non-small lung cancers and its correlation with abnormal p53 nuclear accumulation.
    Mito R; Matsubara E; Komohara Y; Shinchi Y; Sato K; Yoshii D; Ohnishi K; Fujiwara Y; Tomita Y; Ikeda K; Sakagami T; Suzuki M
    Pathol Int; 2020 May; 70(5):287-294. PubMed ID: 32039532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could trop-2 overexpression indicate tumor aggressiveness among prostatic adenocarcinomas?
    Akarken İ; Dere Y
    Ann Diagn Pathol; 2021 Feb; 50():151680. PubMed ID: 33341704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
    Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
    BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXO25 promotes cell proliferation, invasion, and migration of NSCLC.
    Jiang GY; Zhang XP; Wang L; Lin XY; Yu JH; Wang EH; Zhang Y
    Tumour Biol; 2016 Oct; 37(10):14311-14319. PubMed ID: 27596142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical investigation of TROP-2 as an independent biomarker and potential therapeutic target in colon cancer.
    Zhao P; Yu HZ; Cai JH
    Mol Med Rep; 2015 Sep; 12(3):4364-4369. PubMed ID: 26059528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.